January 17, 2020

BLCM Stock Moving Ahead Of ASCO GI Presentation

BLCM stock is moving higher on January 17, 2020, ahead of the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI). Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel,

by Lance Jepsen

Biotechnology

Stock Trading

January 17, 2020

FTSV Stock Up On Oppenheimer Price Target Hike

FTSV stock is up in early trading on January 17, 2020, after Oppenheimer raised its price target on the stock. Oppenheimer analyst Mark Breidenbach raised his price target for Forty Seven

by Lance Jepsen

Biotechnology

Stock Trading

January 16, 2020

TTNP Stock Attracting Buyers After VA Contract

TTNP stock is still attracting buyers after the company announced that it was awarded a VA contract on January 13, 2020. The stock had a big surge in after-hours trading

by Lance Jepsen

Biotechnology

Stock Trading

January 16, 2020

TCON Stock Up On Partner Orphan Designation For Envafolimab

TCON stock rose into the close and then held on to most of those gains in after-hours trading on news its partner was granted FDA orphan designation for envafolimab. 3D Medicines

by Lance Jepsen

Biotechnology

Stock Trading

January 16, 2020

Bullish Options Flow Detected In DVAX Stock

Bullish options flow was detected in DVAX stock on January 16, 2020. Back on December 15, 2019, Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and commercializing novel

by Lance Jepsen

Biotechnology

Stock Trading

January 16, 2020

PTE Stock On the Move After Cantor Fitzgerald Comments

Cantor Fitzgerald analyst Kristen Kluska reiterates an Overweight rating on PolarityTE with a $13 price target. On January 9, a publication featuring the use of SkinTE was published in Plastic

by Lance Jepsen

Biotechnology

Stock Trading

January 16, 2020

NK Stock Surging Higher On Cancer Breakthrough Project

NK stock is surging higher in morning trade on January 16, 2020, after the company released an update on its Cancer Breakthroughs 2020 project. Patrick Soon-Shiong, M.D., Chairman and CEO of

by Lance Jepsen

Biotechnology

Stock Trading

January 13, 2020

NK Stock Higher Into Close On Pancreatic Cancer Shocker!

NK stock ran higher right into the close on January 13, 2020, on shocking news about a pancreatic cancer patient. Rumors are circulating that NantKwest CEO Patrick Soon-Shiong said a cancer

by Lance Jepsen

Biotechnology

Stock Trading

January 13, 2020

AMRN Stock Likely To Rise On Competitors Failures

AMRN stock is likely going to rise after AstraZeneca (AZN) said that it is closing a Phase 3 clinical trial of a fish-oil-derived heart drug, Epanova, after an independent Data

by Lance Jepsen

Biotechnology

Stock Trading

January 13, 2020

ZYME Stock Moving Higher On Agreement with Pfizer

ZYME stock dumped, but now is moving higher in early trading on January 13, 2020, after the company announced an agreement with Pfizer. Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company

by Lance Jepsen

« Older Articles